Green Cross Cell corporation (KOSDAQ:A031390) signed an agreement to acquire CT (cell therapy) business from Green Cross Corporation (KOSE:A006280) for KRW 7.9 billion on February 23, 2017. As of February 23, 2017, the Board of Green Cross Cell corporation resolved the transaction. General meeting of shareholder held on March 17, 2017.

The transaction is expected to close on March 31, 2017. BDO Daejoo LLC acted as an external Rating Institution for Green Cross Cell corporation.